165 related articles for article (PubMed ID: 32917950)
1. Silencing of long non-coding RNA FOXD2-AS1 inhibits the progression of gallbladder cancer by mediating methylation of MLH1.
Gao J; Dai C; Yu X; Yin XB; Liao WJ; Huang Y; Zhou F
Gene Ther; 2021 Jun; 28(6):306-318. PubMed ID: 32917950
[TBL] [Abstract][Full Text] [Related]
2. Overexpression of FOXD2-AS1 enhances proliferation and impairs differentiation of glioma stem cells by activating the NOTCH pathway via TAF-1.
Wang Y; Cheng Y; Yang Q; Kuang L; Liu G
J Cell Mol Med; 2022 May; 26(9):2620-2632. PubMed ID: 35419917
[TBL] [Abstract][Full Text] [Related]
3. LncRNA FOXD2-AS1 knockdown inhibits the resistance of human osteosarcoma cells to cisplatin by inhibiting miR-143 expression.
Zhang QQ; Xu SL; Ding C; Ma CC; Yuan TS; Hua CC; Wang XH
Eur Rev Med Pharmacol Sci; 2021 Jan; 25(2):678-686. PubMed ID: 33577022
[TBL] [Abstract][Full Text] [Related]
4. Silencing lncRNA FOXD2-AS1 inhibits proliferation, migration, invasion and drug resistance of drug-resistant glioma cells and promotes their apoptosis via microRNA-98-5p/CPEB4 axis.
Gu N; Wang X; Di Z; Xiong J; Ma Y; Yan Y; Qian Y; Zhang Q; Yu J
Aging (Albany NY); 2019 Nov; 11(22):10266-10283. PubMed ID: 31770107
[TBL] [Abstract][Full Text] [Related]
5. EGR1-induced upregulation of lncRNA FOXD2-AS1 promotes the progression of hepatocellular carcinoma via epigenetically silencing DKK1 and activating Wnt/β-catenin signaling pathway.
Lei T; Zhu X; Zhu K; Jia F; Li S
Cancer Biol Ther; 2019; 20(7):1007-1016. PubMed ID: 30929558
[TBL] [Abstract][Full Text] [Related]
6. Silence of FOXD2-AS1 inhibited the proliferation and invasion of esophagus cells by regulating miR-145-5p/CDK6 axis.
Shi W; Gao Z; Song J; Wang W
Histol Histopathol; 2020 Sep; 35(9):1013-1021. PubMed ID: 32524576
[TBL] [Abstract][Full Text] [Related]
7. Overexpression of LncRNA AFAP1-AS1 predicts poor prognosis and promotes cells proliferation and invasion in gallbladder cancer.
Ma F; Wang SH; Cai Q; Zhang MD; Yang Y; Ding J
Biomed Pharmacother; 2016 Dec; 84():1249-1255. PubMed ID: 27810781
[TBL] [Abstract][Full Text] [Related]
8. Downregulation of lncRNA FOXD2-AS1 Confers Radiosensitivity to Gastric Cancer Cells via miR-1913/SETD1A Axis.
Guo F; Guo R; Zhang L
Cytogenet Genome Res; 2022; 162(1-2):10-27. PubMed ID: 35354145
[TBL] [Abstract][Full Text] [Related]
9. Knockdown of lncRNA FOXD2-AS1 Inhibits Proliferation, Migration, and Drug Resistance of Breast Cancer Cells.
Nong Q; Yu S; Hu H; Hu X
Comput Math Methods Med; 2021; 2021():9674761. PubMed ID: 34873418
[TBL] [Abstract][Full Text] [Related]
10. Long Non-coding RNA FOXD2-AS1 Promotes Proliferation, Migration, and Invasion in Cholangiocarcinoma Through Regulating miR-760/E2F3 Axis.
Hu Z; Huang L; Wang W; Guan C; Zhao Y; Liu L; Jiang X
Dig Dis Sci; 2022 Feb; 67(2):546-558. PubMed ID: 33570683
[TBL] [Abstract][Full Text] [Related]
11. Long noncoding RNA FOXD2-AS1 promotes glioma malignancy and tumorigenesis via targeting miR-185-5p/CCND2 axis.
Shen F; Chang H; Gao G; Zhang B; Li X; Jin B
J Cell Biochem; 2019 Jun; 120(6):9324-9336. PubMed ID: 30520141
[TBL] [Abstract][Full Text] [Related]
12. Oncogenicity of lncRNA FOXD2-AS1 and its molecular mechanisms in human cancers.
Hu Q; Tai S; Wang J
Pathol Res Pract; 2019 May; 215(5):843-848. PubMed ID: 30723052
[TBL] [Abstract][Full Text] [Related]
13. Long non-coding RNA TNRC6C-AS1 promotes methylation of STK4 to inhibit thyroid carcinoma cell apoptosis and autophagy via Hippo signalling pathway.
Peng X; Ji C; Tan L; Lin S; Zhu Y; Long M; Luo D; Li H
J Cell Mol Med; 2020 Jan; 24(1):304-316. PubMed ID: 31657132
[TBL] [Abstract][Full Text] [Related]
14. Long noncoding FOXD2-AS1 is activated by CREB1 and promotes cell proliferation and metastasis in glioma by sponging miR-185 through targeting AKT1.
Dong H; Cao W; Xue J
Biochem Biophys Res Commun; 2019 Jan; 508(4):1074-1081. PubMed ID: 30553445
[TBL] [Abstract][Full Text] [Related]
15. m
Ji F; Lu Y; Chen S; Lin X; Yu Y; Zhu Y; Luo X
Mol Ther Oncolytics; 2021 Sep; 22():574-581. PubMed ID: 34589576
[TBL] [Abstract][Full Text] [Related]
16. Long non-coding RNA PRRT3-AS1 silencing inhibits prostate cancer cell proliferation and promotes apoptosis and autophagy.
Fan L; Li H; Wang W
Exp Physiol; 2020 May; 105(5):793-808. PubMed ID: 32086850
[TBL] [Abstract][Full Text] [Related]
17. Long non-coding RNA BZRAP1-AS1 silencing suppresses tumor angiogenesis in hepatocellular carcinoma by mediating THBS1 methylation.
Wang W; Chen G; Wang B; Yuan Z; Liu G; Niu B; Chen Y; Zhou S; He J; Xue H
J Transl Med; 2019 Dec; 17(1):421. PubMed ID: 31847842
[TBL] [Abstract][Full Text] [Related]
18. FOXD2-AS1 correlates with the malignant status and regulates cell proliferation, migration, and invasion in cutaneous melanoma.
Ren W; Zhu Z; Wu L
J Cell Biochem; 2019 Apr; 120(4):5417-5423. PubMed ID: 30426532
[TBL] [Abstract][Full Text] [Related]
19. Long non-coding RNA FOXD2-AS1 functions as a tumor promoter in colorectal cancer by regulating EMT and Notch signaling pathway.
Yang X; Duan B; Zhou X
Eur Rev Med Pharmacol Sci; 2017 Aug; 21(16):3586-3591. PubMed ID: 28925486
[TBL] [Abstract][Full Text] [Related]
20. The long non-coding RNA FOXD2-AS1 promotes bladder cancer progression and recurrence through a positive feedback loop with Akt and E2F1.
Su F; He W; Chen C; Liu M; Liu H; Xue F; Bi J; Xu D; Zhao Y; Huang J; Lin T; Jiang C
Cell Death Dis; 2018 Feb; 9(2):233. PubMed ID: 29445134
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
